Open AccessP1210: IMMUNE CORRELATES OF RESPONSE TO GLOFITAMAB: BIOMARKER FINDINGS FROM A PIVOTAL PHASE II EXPANSION STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)
Author(s) -
Piccione E. C.,
Belousov A.,
Hamidi H.,
CarloStella C.,
Dickinson M.,
Morschhauser F.,
Lundberg L.,
Humphrey K.,
Tracy S.,
Hutchings M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847704.12245.1f
Subject(s) - cd20 , medicine , cd8 , diffuse large b cell lymphoma , immune system , lymphoma , gastroenterology , oncology , immunology